A customer from (b)(6) notified biomérieux of obtaining elevated ck-mb results for a (b)(6) boy in association with the vidas® ck mb assay (ref (b)(4)).Although product reference (b)(4) is not sold/ distributed in the united states, a similar product is (reference (b)(4)).The patient had complained of a stabbing pain his chest after exercise.He had moved benches at school and played football.He was admitted to the children's ward for observation, and labs were drawn showing the following results: (b)(6) 2018: troponin - 10.1 ng / ml, ck-mb - 116.15 ng / ml, ecg - normal.(b)(6) 2018: troponin - 3.6 ng / ml, ck-mb - 133.97 ng / ml.(b)(6) 2018: ck-mb - 202.99 ng / ml, repeated in serum diluted 11 times = 17.1 ng / ml x 11 = 188.1 ng / ml.The chest pain was transient, and the patient was reported by the customer as feeling well.As the vidas ck-mb test was performed after a sport exercise at school, the elevation of ck-mb could have been due to muscular hyperactivity.However, the result continued to increase.The customer reported testing one of the patient samples with the vidas ckmb assay and obtaining a > 300 result.This same sample was testing with cobas® (roche diagnostics), and it returned a ck-mb result in the normal range.The customer reported that the patient was discharged home without treatment.There is no indication or report from the laboratory that the discrepant result led to any adverse event related to any patient's state of health.Note: the two techniques, vidas and cobas, use different technologies and different antibodies for the detection of ck-mb.An internal biomérieux investigation will be initiated.
|
An internal investigation was performed for elevated ck-mb results for a 14-year-old boy in association with the vidas® ck mb assay (ref 30421).Complaint trending analysis confirmed there is no other complaint on this lot vidas ckmb 1006271330 /190117-0 for the same issue.The batch history records for the lot vidas ckmb 1006271330 /190117-0 show no anomaly during the manufacturing and control process, and no non-conformity.A study of internal sample control charts for five internal samples with different concentrations on six batches including the batch mentioned by the customer, confirmed results were within specifications.Vidas ckmb 1006271330 /190117-0 is in the trend compared to the other batches.Testing included six internal samples with the lot vidas ckmb 1006271330 /190117-0.The results were within the expected values and there was no evolution since batch release.Ckmb64 :19.79 ng/ml ckmb41 :72.24 ng/ml ckmb54 :27.84 ng/ml ckmb37 :184.33 ng/ml ck13 : 1.76ng/ml ck21 : 1.66ng/ml regarding these six internal samples, we did not reproduced the customer's anomaly.The elevated result with vidas ckmb seems to be linked to the specific sample.Without the customer sample we cannot pursue the investigation.Note: the two techniques mentioned by the customer, vidas and cobas, use different technologies and different antibodies.
|